News – Page 986 – Endpoints News

Parker-backed cancer scientists shine a light on an emerging pathway in pancreatic cancer

7 years ago

Kaleido, Cirius brace the IPO market seeking a combined $186M — despite barriers at shutdown-mode SEC

7 years ago

Aslan turns focus to biliary tract cancer as lead drug flops in PhII gastric cancer study

7 years ago

Ironwood recruits CMO on the eve of split-up; Roche vet Margrit Schwarz joins Genevant

7 years ago

Early research suggests existing drugs could strangle building blocks of metastasis

7 years ago

So what did we learn from JPMorgan week? Buckle up, it’s going to be a bumpy ride

7 years ago

Anti-aging startup Elevian enlists Insilico on AI quest for 'young blood'

7 years ago

Computational scientists design a new IL-2 cancer drug and spin it out into a biotech startup

7 years ago

J&J hikes US prices for a basket of drugs, including certain top-sellers — Reuters

7 years ago

As JPMorgan madness subsides, Democrats will unveil a legislative package to address drug price hikes

7 years ago

CANbridge expands rare disease pact with WuXi Biologics; Watch for a manufacturing site from Allogene

7 years ago

AstraZeneca chops 210 workers, closes sites as it looks to concentrate biologics manufacturing in one place

7 years ago

NICE rejects Novartis' migraine drug Aimovig, months after declining to endorse pricey Kymriah for adult use

7 years ago

Roche exec Pearl Huang rejoins biotech as CEO of Cygnal — Flagship's bet on 'exoneural biology'

7 years ago

Betting on allosteric mutations driving cancer, Black Diamond raises $85M in fresh round

7 years ago

The first patient has been treated under the controversial 'right to try' law

7 years ago

Roche names new Foundation Med chief; Akorn shares dip on FDA warning letter; Zai Lab advances pivotal PARP study

7 years ago

Denali broadens tech to infiltrate the blood-brain barrier with Sirion deal

7 years ago

Anti-aging startup Unity dives into eye diseases as partnership with Ascentage bears fruit

7 years ago

‘It’s us against the world’: And George Yancopoulos wants you to know they are beating the world — big time

7 years ago

How to build a biotech unicorn: Get the star team in place, attract deep-pocket VCs, paint a big picture and raise up ...

7 years ago

As it digests Shire, Takeda plans to shed $10B in non-core assets to relieve debt burden

7 years ago

Bluebird endorses plan for installment-based payments for costly gene therapy

7 years ago

Lilly to display drug pricing info on website; Catalent pledges $200M for its biologics unit

7 years ago

First page Previous page 983 984 985986987 988 989 Next page Last page